Dermata Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 12.86 K | $138 | 100.00% | 0.83% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 12.00 K | $16.20 K | 0.00% | 0.77% |
| UBS GROUP AG | 02/14/2025 | 4.14 K | $46 | -2.36% | 0.27% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 1.35 K | $14 | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 100 | $1 | 0.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dermata Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Dermata Therapeutics, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 0
BANK OF AMERICA CORP /DE/: 100
Empery Asset Management, LP: 175,000
1.96% of Dermata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 175.10 K shares in the last 24 months. This purchase volume represents approximately $3.50 K in transactions.